人工智慧（AI）在医疗预测分析领域的市场－策略分析与预测（2026-2031年）

预计到 2026 年，医疗保健领域预测分析的人工智慧 (AI) 市场规模将达到 105 亿美元，到 2031 年将达到 621 亿美元，复合年增长率为 42.7%。

医疗保健领域的人工智慧（AI）预测分析市场策略性地定位于数位健康、巨量资料和临床决策支援的交汇点。医疗保健系统面临着在控製成本的同时提高治疗效果的压力。人工智慧驱动的预测分析能够实现早期风险识别、个人化治疗方案製定和资源优化。其主要驱动因素包括慢性病盛行率的上升、人口老化以及向价值医疗模式的转变。医院和医疗服务提供者正在加速将数据驱动工具整合到其营运流程和临床工作流程中，该市场正逐渐成为下一代医疗保健基础设施的核心组成部分。

市场驱动因素

成长要素的主要因素是电子健康记录、医学影像和穿戴式装置产生的医疗数据量不断增长。基于人工智慧的分析解决方案可以将这些数据转化为可操作的洞察，用于疾病预测和护理管理。另一个关键因素是对早期诊断和预防医学的需求。预测模型可以帮助临床医生识别高风险患者，并在併发症发生前进行干预。政府支持数位化医疗的措施也在推动市场成长。对医疗保健IT基础设施和云端平台的投资进一步促进了大规模部署。此外，降低再入院率和提高营运效率的需求也在推动医疗机构采用预测分析工具。

市场限制因素

对资料隐私和安全的担忧仍然是推广应用的主要障碍。医疗保健数据高度敏感，监管合规要求也增加了实施的复杂性。人工智慧软体整合和系统客製化的高成本限制了其在小规模医疗机构中的应用。熟练的资料科学和临床资讯学专业人员的短缺也减缓了其应用。旧有系统和新型人工智慧平台之间的互通性挑战阻碍了资料的无缝交换。关于演算法透明度和偏见的伦理问题也会影响使用者信任和监管机构的接受度。

技术与细分市场洞察

该市场可按组件、应用和最终用户进行细分。按组件划分，包括软体平台及相关服务，例如係统整合和支援。由于演算法的持续发展和分析能力的不断提升，软体占据主导地位。按应用划分，疾病预测、人群健康管理、医院工作流程优化和临床决策支援是主要细分市场。疾病风险预测和病患监测占据较大的市场份额，因为它们直接影响治疗结果。最终使用者包括医院、诊所、诊断中心和研究机构。医院是最大的细分市场，这得益于其庞大的患者群体和对营运效率工具的高需求。与本地部署系统相比，云端部署具有扩充性和更低的基础架构成本，因此越来越受欢迎。

竞争格局与策略展望

竞争格局由科技公司、医疗资讯科技供应商和分析专家共同塑造。策略重点领域包括提高模型准确性、拓展临床应用案例以及与医疗服务提供者建立合作关係。各公司正投资于合规框架，以应对监管要求和资料安全风险。产品差异化主要体现在与现有医院资讯系统和电子健康记录(EHR) 的整合能力。区域扩大策略瞄准医疗数位化程度高且法规环境完善的市场。併购和合作正被用来增强资料存取和分析能力。

医疗保健领域预测分析的人工智慧（AI）市场正进入快速商业化阶段。数位医疗的普及和预防性医疗模式的需求是推动市场成长的主要动力。儘管资料安全和成本挑战依然存在，但持续的创新和政策支持预计将使市场保持强劲成长势头直至2031年。

本报告的主要益处：

• 深入分析：透过专注于客户群、政府政策和社会经济因素、消费者偏好、行业特定数据以及其他细分市场，您可以获得详细的市场洞察，不仅涵盖主要地区，还涵盖新兴地区。
• 竞争格局：了解主要企业所采用的策略策略，可以帮助您掌握透过正确策略打入市场的潜力。
• 市场驱动因素与未来趋势：我们将探讨动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
• 可操作的建议：利用洞察力进行策略决策，在动态环境中发掘新的业务管道和收入来源。
• 适用于广泛的使用者群体：对新兴企业、研究机构、顾问公司、中小企业和大型企业都具有良好的效益和成本效益。

你用它来做什么？

产业和市场分析、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范和影响、新产品开发以及竞争影响。

分析范围

• 历史资料（2021-2024 年）、基准年（2025 年）和预测资料（2026-2031 年）
• 成长机会、挑战、供应链前景、法规结构、顾客行为和趋势分析。
• 竞争对手定位、策略和市场占有率分析
• 营收成长率及预测分析：依业务板块及地区（国家）划分
• 企业概况（策略、产品、财务资讯、关键趋势等）

目录

第一章：引言

• 市场概览
• 市场的定义
• 分析范围
• 市场区隔
• 货币
• 先决条件
• 基准年和预测年的时间轴
• 相关人员的主要收益

第二章 分析方法

• 分析数据
• 分析过程

第三章执行摘要

• 分析概要
• 高阶主管（CXO）的观点

第四章 市场动态

• 市场驱动因素
• 市场限制因素
• 波特五力分析
• 产业价值链分析
• 分析师意见

第五章：人工智慧（AI）在医疗预测分析领域的市场：以部署方式划分

• 基于云端的
• 现场

第六章：人工智慧（AI）在医疗预测分析领域的市场：按应用划分

• 患者风险分层
• 疾病诊断与预后
• 团体健康管理
• 诈欺侦测
• 供应链管理
• 其他的

第七章：人工智慧（AI）在医疗预测分析领域的市场：依最终用户划分

• 医院和诊所
• 健康保险提供者
• 製药和生物技术公司
• 研究机构和学术中心
• 其他的

第八章：人工智慧（AI）在医疗预测分析领域的市场：按地区划分

• 北美洲
  • 透过部署方法
  • 透过使用
  • 最终用户
  • 国家
    • 我们
    • 加拿大
    • 墨西哥
• 南美洲
  • 透过部署方法
  • 透过使用
  • 最终用户
  • 国家
    • 巴西
    • 阿根廷
    • 其他的
• 欧洲
  • 透过部署方法
  • 透过使用
  • 最终用户
  • 国家
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
• 中东和非洲
  • 透过部署方法
  • 透过使用
  • 最终用户
  • 国家
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
• 亚太地区
  • 透过部署方法
  • 透过使用
  • 最终用户
  • 国家
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 台湾
    • 其他的

第九章：竞争环境与分析

• 主要企业及策略分析
• 新兴企业和市场盈利
• 企业合併、协议、商业合作
• 供应商投资人矩阵

第十章：公司简介

• Ibm Corporation
• Microsoft Corporation
• Google Llc（Alphabet Inc.）
• Sas Institute Inc.
• Oracle Corporation
• Cerner Corporation
• Allscripts Healthcare Solutions, Inc.
• Medeanalytics, Inc.
• Ayasdi, Inc.
• Health Catalyst, Inc.

The Artificial Intelligence (AI) in Predictive Healthcare Analytics market is forecast to grow at a CAGR of 42.7%, reaching USD 62.1 billion in 2031 from USD 10.5 billion in 2026.

The Artificial Intelligence in predictive healthcare analytics market is strategically positioned at the intersection of digital health, big data, and clinical decision support. Healthcare systems are under pressure to improve outcomes while controlling costs. Predictive analytics powered by AI enables early risk identification, personalized treatment planning, and optimized resource utilization. Macro drivers include rising chronic disease burden, aging populations, and the shift toward value-based care models. Hospitals and healthcare providers are increasingly integrating data-driven tools into operational and clinical workflows. This positions the market as a core component of next-generation healthcare infrastructure.

Market Drivers

The primary growth driver is the expanding volume of healthcare data generated from electronic health records, medical imaging, and wearable devices. AI-based analytics solutions convert this data into actionable insights for disease prediction and care management. Another key driver is the demand for early diagnosis and preventive healthcare. Predictive models help clinicians identify high-risk patients and intervene before complications arise. Government initiatives supporting digital health adoption also stimulate market growth. Investments in healthcare IT infrastructure and cloud-based platforms further support large-scale deployment. In addition, the need to reduce hospital readmissions and improve operational efficiency encourages adoption of predictive analytics tools across care settings.

Market Restraints

Data privacy and security concerns remain major barriers to adoption. Healthcare data is highly sensitive, and regulatory compliance requirements increase implementation complexity. High costs associated with AI software integration and system customization limit adoption among smaller healthcare facilities. Limited availability of skilled professionals in data science and clinical informatics slows deployment. Interoperability challenges between legacy systems and new AI platforms restrict seamless data exchange. Ethical concerns related to algorithm transparency and bias also affect user trust and regulatory acceptance.

Technology and Segment Insights

The market can be segmented by component, application, and end user. By component, solutions include software platforms and associated services such as system integration and support. Software dominates due to continuous algorithm development and analytics upgrades. By application, key segments include disease prediction, population health management, hospital workflow optimization, and clinical decision support. Disease risk prediction and patient monitoring account for significant market share due to their direct impact on treatment outcomes. End users include hospitals, clinics, diagnostic centers, and research institutions. Hospitals represent the largest segment because of high patient volumes and strong demand for operational efficiency tools. Cloud-based deployment is gaining traction due to scalability and lower infrastructure costs compared to on-premise systems.

Competitive and Strategic Outlook

The competitive landscape is shaped by technology companies, healthcare IT providers, and analytics specialists. Strategic focus areas include improving model accuracy, expanding clinical use cases, and forming partnerships with healthcare providers. Companies are investing in compliance frameworks to address regulatory requirements and data security risks. Product differentiation is driven by integration capabilities with existing hospital information systems and electronic health records. Regional expansion strategies target markets with strong healthcare digitization and supportive regulatory environments. Mergers and collaborations are used to enhance data access and analytics expertise.

The Artificial Intelligence in predictive healthcare analytics market is entering a phase of rapid commercialization. Growth is supported by digital health adoption and the need for proactive care models. While data security and cost challenges remain, continuous innovation and policy support are expected to sustain strong market expansion through 2031.

Key Benefits of this Report

• Insightful Analysis: Gain detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
• Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
• Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
• Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
• Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

• Historical data from 2021 to 2024, Base Year 2025, Forecast Years 2026-2031
• Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
• Competitive positioning, strategies, and market share evaluation
• Revenue growth and forecast assessment across segments and regions
• Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. CXO Perspective

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. ARTIFICIAL INTELLIGENCE (AI) IN PREDICTIVE HEALTHCARE ANALYTICS MARKET BY DEPLOYMENT MODE

• 5.1. Introduction
• 5.2. Cloud-Based
• 5.3. On-Premise

6. ARTIFICIAL INTELLIGENCE (AI) IN PREDICTIVE HEALTHCARE ANALYTICS MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Patient Risk Stratification
• 6.3. Disease Diagnosis And Prognosis
• 6.4. Population Health Management
• 6.5. Fraud Detection
• 6.6. Supply Chain Management
• 6.7. Others

7. ARTIFICIAL INTELLIGENCE (AI) IN PREDICTIVE HEALTHCARE ANALYTICS MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals And Clinics
• 7.3. Healthcare Payers
• 7.4. Pharmaceutical And Biotechnology Companies
• 7.5. Research Institutes And Academic Centers
• 7.6. Others

8. ARTIFICIAL INTELLIGENCE (AI) IN PREDICTIVE HEALTHCARE ANALYTICS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Deployment Mode
  • 8.2.2. By Application
  • 8.2.3. BY End-User
  • 8.2.4. By Country
    • 8.2.4.1. United States
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Deployment Mode
  • 8.3.2. By Application
  • 8.3.3. BY End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Deployment Mode
  • 8.4.2. By Application
  • 8.4.3. BY End-User
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Italy
    • 8.4.4.5. Spain
    • 8.4.4.6. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Deployment Mode
  • 8.5.2. By Application
  • 8.5.3. BY End-User
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Deployment Mode
  • 8.6.2. By Application
  • 8.6.3. BY End-User
  • 8.6.4. By Country
    • 8.6.4.1. Japan
    • 8.6.4.2. China
    • 8.6.4.3. India
    • 8.6.4.4. South Korea
    • 8.6.4.5. Indonesia
    • 8.6.4.6. Taiwan
    • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Ibm Corporation
• 10.2. Microsoft Corporation
• 10.3. Google Llc (Alphabet Inc.)
• 10.4. Sas Institute Inc.
• 10.5. Oracle Corporation
• 10.6. Cerner Corporation
• 10.7. Allscripts Healthcare Solutions, Inc.
• 10.8. Medeanalytics, Inc.
• 10.9. Ayasdi, Inc.
• 10.10. Health Catalyst, Inc.